THE ROLE OF ENDOGENOUS VASOPRESSIN AND OXYTOCIN IN RESTRICTED BRAIN-AREAS ON PASSIVE-AVOIDANCE BEHAVIOR

被引:0
|
作者
GREIDANUS, TBV
BAARS, A
机构
关键词
ANTIVASOPRESSIN SERUM; ANTI-OXYTOCIN SERUM; DORSAL HIPPOCAMPUS; LATERAL HABENULAR REGION; DORSAL RAPHE NUCLEUS; PASSIVE AVOIDANCE BEHAVIOR; MEMORY PROCESSES;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Local application of antiserum against vasopressin in a 1 : 50 dilution in the dorsal raphe nucleus attenuates passive avoidance behavior of rats when micro-injected either immediately after the learning trial or prior to retention. A similar micro-injection into the lateral habenular region attenuates passive avoidance only upon preretention treatment, but not when given post-learning. Local application of anti-oxytocin serum in the dorsal hippocampal/dentate gyrus area, in the dorsal raphe nucleus or in the lateral habenular region does not affect passive avoidance behavior. It is concluded that the local presence or release of endogenous vasopressin in the dorsal raphe nucleus plays a role in memory processes related to storage as well as retrieval of information, whereas endogenous vasopressin in the lateral habenular region is only involved in retrieval.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 50 条
  • [21] EFFECTS OF INTRACEREBROVENTRICULAR ADMINISTRATION OF OVINE CORTICOTROPIN-RELEASING FACTOR (CRF 1-41) ON PASSIVE-AVOIDANCE BEHAVIOR - LACK OF INFLUENCE ON MONOAMINE CONTENTS OF LIMBIC BRAIN-AREAS
    FEKETE, M
    BALAZS, M
    TELEGDY, G
    SCHALLY, AV
    NEUROPEPTIDES, 1985, 6 (04) : 283 - 292
  • [22] LEVELS OF ARGININE-VASOPRESSIN IN CEREBROSPINAL-FLUID DURING PASSIVE-AVOIDANCE BEHAVIOR IN RATS
    LACZI, F
    GAFFORI, O
    FEKETE, M
    DEKLOET, ER
    DEWIED, D
    LIFE SCIENCES, 1984, 34 (24) : 2385 - 2391
  • [23] VASOPRESSIN AND OXYTOCIN CONTENT IN CEREBROSPINAL-FLUID AND IN VARIOUS BRAIN-AREAS AFTER ADMINISTRATION OF HISTAMINE AND PENTYLENETETRAZOL
    MENS, WBJ
    LACZI, F
    TONNAER, JADM
    DEKLOET, ER
    GREIDANUS, TBV
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1983, 19 (04) : 587 - 591
  • [24] EFFECTS OF BREMAZOCINE ON PASSIVE-AVOIDANCE BEHAVIOR IN MICE
    CASTELLANO, C
    PAVONE, F
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1986, 283 (02): : 199 - 208
  • [25] IS THE STRIATUM INVOLVED IN PASSIVE-AVOIDANCE BEHAVIOR - A COMMENTARY
    POLGAR, S
    SANBERG, PR
    KIRKBY, RJ
    PHYSIOLOGICAL PSYCHOLOGY, 1981, 9 (04): : 354 - 358
  • [26] PASSIVE-AVOIDANCE BEHAVIOR AND THE IMMUNE-SYSTEM
    CROISET, G
    HEIJNEN, CJ
    DEWIED, D
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (05) : 292 - 292
  • [27] EFFECT OF FIPEXIDE ON PASSIVE-AVOIDANCE BEHAVIOR IN RATS
    SERRA, G
    COLLU, M
    MARTELLOTTA, MC
    FORGIONE, A
    FRATTA, W
    PHARMACOLOGICAL RESEARCH, 1989, 21 (05) : 603 - 608
  • [28] CONDITIONS OF PREEXPOSURE AND PASSIVE-AVOIDANCE BEHAVIOR IN RATS
    MELLGREN, RL
    HUNSICKER, JP
    DYCK, DG
    ANIMAL LEARNING & BEHAVIOR, 1975, 3 (02): : 147 - 151
  • [29] PASSIVE-AVOIDANCE BEHAVIOR OF SPONTANEOUSLY HYPERTENSIVE RATS
    KNARDAHL, S
    KARLSEN, K
    BEHAVIORAL AND NEURAL BIOLOGY, 1984, 42 (01): : 9 - 22
  • [30] ACTH RELEASE DURING PASSIVE-AVOIDANCE BEHAVIOR
    VANWIMERSMAGREIDANUS, TB
    REES, LH
    SCOTT, AP
    LOWRY, PJ
    DEWIED, D
    BRAIN RESEARCH BULLETIN, 1977, 2 (02) : 101 - 104